Bio Pharma Buffer Market Size, Share, Growth, and Industry Analysis, by Type (Phosphates Type, Acetates Type, TRIS Type, and Others), By Application (Research Institution, Pharmaceutical Industry, and Others), Regional Forecast To 2031

Updated On: 01 April 2024

Bio Pharma Buffer Market REPORT OVERVIEW

• 
• Request Free Sample PDF to learn more about this report

The global bio pharma buffer market size was USD 823.1 million in 2021 and market is projected to touch USD 1693 million by 2031, at a compound annual growth rate (CAGR) of 7.5% during the forecast period.

The bio pharma buffer is made up of the active component which is necessary for the pH of the blood and tissue. It maintains positive health and well-being at any stage of life. A bio pharma buffer is a buffer that can be used to stabilize proteins and other biological proteins. Some of these may also be used as buffers for different procedures in the health industry. It is a type of buffer chemical used in the pharmaceutical industry and is added to a drug formulation to ensure that the product remains stable and retains its potency over time.

To keep medications potent and stable for several years, manufacturers use bio pharma buffers. These products help to retain the potency of active ingredients by retaining moisture and preventing oxidation, which would otherwise alter the quality of medication. This is one of the most critical components of pharmaceutical products. To retain potency and stability of active ingredients by retaining moisture, manufacturers use this product in different forms, including granular and liquid. The demand for bio pharma buffers has increased due to their presence as an ingredient in various types of drug formulations such as generic tablets, chewable, and capsules.

COVID-19 Impact: The Slowdown in Production Hampered Market Growth.

The COVID-19 pandemic has had a considerable influence on the global industry and working conditions, particularly among healthcare practitioners who are keeping patients at home as a preventative measure. In terms of production and sales, COVID-19 has negatively affected the biopharma buffer market. The implementation of COVID-19 has led to the halving of the bio pharma market in 2019 and 2020, with tariff price hikes being bearish due to the slowdown of exports, logistics issues, and foreign exchange restrictions. Furthermore, the COVID-19 pandemic has disrupted many industries throughout the world, including healthcare.

LATEST TRENDS

"Technological Advancement Triggers a Rise in Market Demand."

The bio pharma buffer market is growing swiftly, and companies are increasing the effectiveness of their products through the utilization of advanced technologies. As the market is growing rapidly, there has been demand for a greater range of products and services. The demand for cost-effective manufacturing processes has made it necessary to innovate in order to offer more value. Companies are increasingly looking at capitalizing on technology and investing in R&D in order to increase their competitiveness and profitability. The market is growing significantly due to eco-friendly products, innovative delivery systems, and high demand for specialty buffers.

Bio Pharma Buffer Market SEGMENTATION

• 
• Request Free Sample PDF to learn more about this report

• By Type

Based on type; the market is divided into Phosphates Type, Acetates Type, TRIS Type, and Others

Phosphates Type is the leading part of this segment.

• By Application

Based on application; the market is divided into Research Institution, Pharmaceutical Industry, and Others

Pharmaceutical Industry is the leading part of the application segment.

DRIVING FACTORS

"Wide Applications of the Product Lead to an Increase in Market Growth"

Bio pharma buffer market is expected to be driven by an increase in demand for pharmaceuticals and medicines in emerging countries. Additionally, the rise in health insurance premiums and increasing healthcare expenditure will have a positive impact on the market. During the forecast period, demand for biopharmaceutical buffers from the government and consumers would rise. Currently, the biopharma buffer market is affecting a variety of industries, including cosmetics, food and beverage, and healthcare. The increasing awareness among consumers about the sustainability of the products being used in these activities is making them more aware of their performance and identity. Due to this, manufacturers are seeking new ways to produce eco-friendly bio pharma buffers in line with the standards set by consumers.

"Active Participation in the R&D Enhanced Market Demand"

The bio pharma buffer market growth is expected to witness a high turn in the next few years, and with the increasing popularity of this type of treatment, the demand for such products has increased. The main factors for the growth of this market are the use of innovative and technical parameters in manufacturing, increasing demand for continuous processing of pharmaceutical products; increase in concentration of active ingredients in its production processes, development of new functional materials from renewable sources; rise in consumer awareness regarding effective antioxidants and antioxidant supplementation recommendations.

RESTRAINING FACTORS

"High Price Lead to Impede Market Demand"

The main disadvantages of these products are high cost and slow production. High cost is the biggest concern for all industries because it increases the product price, which ultimately affects the customer base. This is because of high raw material prices, manufacturing processes, product stability, and shelf life issues. Add to this, the rising prices of raw materials required for production, and you have a tough time making a profit. Moreover, one should consider biopharmaceuticals for several factors, such as stability, temperature range. As stability is an important factor, any change in it can reduce the quality of the product and discolor or degrade it as well.

Bio Pharma Buffer Market REGIONAL INSIGHTS

• 
• Request Free Sample PDF to learn more about this report

"North America to Lead Market Owing to the Increasing Geriatric Population"

The North American area is expected to see significant growth in demand for bio pharma buffer market share. They are growing in popularity with clients as a result of their effectiveness and creative applications. The market share for biopharmaceutical buffers is expected to expand significantly in the North American area. This can be due to the rising prevalence of chronic diseases among the ageing population and the growing geriatric population. Many pharmaceutical companies have started developing highly creative products in recent years.

KEY INDUSTRY PLAYERS

"Important Players in the Market to Accelerate Market Growth"

Several sources provided the data that was used to analyses this market. Trade publications, statistics from professional associations, scholarly research, and government reports are a few examples of these sources. Additionally, data is acquired from a variety of sources, including manufacturers, suppliers, retailers, micro-experts, and other players in the international market. Information about industry participants and their activity in the sector is provided in the report. A few examples of information gathering and reporting methods include partnerships, technological developments, acquisitions, mergers, and the expansion of industrial facilities.

List of Market Players Profiled

• Becton Dickinson (BD) U.S.)
• Cardinal Health (U.S.)
• Techcon Systems (U.S.)
• Thermo Fisher Scientific (U.S.)
• Masterflex (Germany)
• Quality Lab Accessories (QLA) (U.S.)
• Sklar (U.S.)
• Unimed (Switzerland‎)
• Conmed (U.S.)
• Accutome (U.S.)
• Charles River Laboratories (U.S)
• Thorlabs (U.S.)
• Chemglass (U.S.)
• Avanos Medical (U.S.)
• Nihon Chushashin Kogyo (Japan)
• Ace Glass (U.S.)
• Socorex (Switzerland)
• Radnoti (U.S.)
• Allied Way (India)
• World Precision Instruments (WPI) (U.S.)

REPORT COVERAGE

The study offers a thorough examination of the current status of the market, accounting for all significant elements such as raw materials, technology, and equipment, as well as supply and demand, production capacity, and industry chain analysis. The market potential and market dangers related to the growth of particular segments are assessed in this study. To determine how these factors will affect the market's expansion, the primary drivers and constraints are also studied. The performance of important companies is evaluated for the anticipated time, and their contributions to market dynamics are examined.